Effects of a HLA-B*15:02 screening policy on antiepileptic drug use and severe skin reactions.

Abstract

OBJECTIVE To assess the effects of an active pharmacogenetic screening policy for antiepileptic drug (AED) therapy on everyday clinical practice and clinical outcomes. METHODS We extracted data covering all public hospitals and clinics in Hong Kong for patients who were newly commenced on carbamazepine or other AEDs, or were tested for HLA-B*15:02 3 years… (More)
DOI: 10.1212/WNL.0000000000001034

4 Figures and Tables

Topics

  • Presentations referencing similar topics